StartupsFinSMEsabout 1 hour ago
GT Metabolic Solutions Gets Series C Funding
1 min read
GT Metabolic Solutions, a Minneapolis medical device firm, received a Series C investment from J.P. Morgan Life Sciences Private Capital on 28/10/2026. The deal amount was not disclosed. The company plans to use the funds for its global commercial launch and expansion into new surgical and therapeutic settings.
Level
Hype check
Tap to vote and see what everyone thinks.